Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program
- PMID: 26585409
- DOI: 10.1176/appi.ajp.2015.15010130
Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program
Abstract
Objective: This study evaluated the impact of antipsychotic review, social interaction, and exercise, in conjunction with person-centered care, on antipsychotic use, agitation, and depression in people with dementia living in nursing homes.
Method: A cluster-randomized factorial controlled trial with two replications was conducted in people with dementia in 16 U.K. nursing homes. All homes received training in person-centered care. Eight homes were randomly assigned to antipsychotic review, to a social interaction intervention, and to an exercise intervention for 9 months, with most homes assigned to more than one intervention. The primary outcome measures were antipsychotic use, agitation, and depression. Secondary outcome measures were overall neuropsychiatric symptoms and mortality.
Results: Antipsychotic review significantly reduced antipsychotic use by 50% (odds ratio 0.17, 95% confidence interval [CI] 0.05 to 0.60). Antipsychotic review plus the social interaction intervention significantly reduced mortality (odds ratio 0.26, 95% CI 0.13 to 0.51) compared with the group receiving neither. The group receiving antipsychotic review but not the social intervention showed significantly worse outcome in neuropsychiatric symptoms compared with the group receiving neither (score difference +7.37, 95% CI 1.53 to 13.22). This detrimental impact was mitigated by concurrent delivery of the social intervention (-0.44, CI -4.39 to 3.52). The exercise intervention significantly improved neuropsychiatric symptoms (-3.59, 95% CI -7.08 to -0.09) but not depression (-1.21, CI -4.35 to 1.93). None of the interventions had a significant impact specifically on agitation.
Conclusions: While reductions in antipsychotic use can be achieved by using a "real world" intervention, this may not be of benefit to people with dementia in the current climate of more judicious prescribing unless nonpharmacological interventions such as social interaction or exercise are provided in parallel.
Comment in
-
Isn't Your Staff Trained To Manage My Mother?Am J Psychiatry. 2016 Mar 1;173(3):205-7. doi: 10.1176/appi.ajp.2016.16010028. Am J Psychiatry. 2016. PMID: 26926122 No abstract available.
Similar articles
-
Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial.PLoS Med. 2018 Feb 6;15(2):e1002500. doi: 10.1371/journal.pmed.1002500. eCollection 2018 Feb. PLoS Med. 2018. PMID: 29408901 Free PMC article. Clinical Trial.
-
Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD-a factorial cluster randomised controlled trial.Int J Geriatr Psychiatry. 2017 Oct;32(10):1094-1103. doi: 10.1002/gps.4572. Epub 2016 Sep 19. Int J Geriatr Psychiatry. 2017. PMID: 27640872 Clinical Trial.
-
Improving mental health and reducing antipsychotic use in people with dementia in care homes: the WHELD research programme including two RCTs.Southampton (UK): NIHR Journals Library; 2020 Jul. Southampton (UK): NIHR Journals Library; 2020 Jul. PMID: 32721145 Free Books & Documents. Review.
-
Apathy and Its Response to Antipsychotic Review and Nonpharmacological Interventions in People With Dementia Living in Nursing Homes: WHELD, a Factorial Cluster Randomized Controlled Trial.J Am Med Dir Assoc. 2016 Aug 1;17(8):741-7. doi: 10.1016/j.jamda.2016.04.006. Epub 2016 May 12. J Am Med Dir Assoc. 2016. PMID: 27184521 Clinical Trial.
-
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007726. doi: 10.1002/14651858.CD007726.pub2. Cochrane Database Syst Rev. 2013. PMID: 23543555 Review.
Cited by
-
Health Care Team Interventions to Reduce Distress Behaviors in Older Adults: A Systematic Review.Clin Gerontol. 2024 Oct-Dec;47(5):730-745. doi: 10.1080/07317115.2024.2372424. Epub 2024 Jul 2. Clin Gerontol. 2024. PMID: 38954524 Review.
-
GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimer's Disease through its Supporting DPP4 Inhibitors: A Review.Curr Top Med Chem. 2024;24(19):1635-1664. doi: 10.2174/0115680266293416240515075450. Curr Top Med Chem. 2024. PMID: 38803170 Review.
-
Developing an ontology of non-pharmacological treatment for emotional and mood disturbances in dementia.Sci Rep. 2024 Jan 22;14(1):1937. doi: 10.1038/s41598-023-46226-5. Sci Rep. 2024. PMID: 38253678 Free PMC article.
-
Medication Reviews and Clinical Outcomes in Persons with Dementia: A Scoping Review.Pharmacy (Basel). 2023 Oct 20;11(5):168. doi: 10.3390/pharmacy11050168. Pharmacy (Basel). 2023. PMID: 37888512 Free PMC article. Review.
-
Understanding neuropsychiatric symptoms in Alzheimer's disease: challenges and advances in diagnosis and treatment.Front Neurosci. 2023 Sep 5;17:1263771. doi: 10.3389/fnins.2023.1263771. eCollection 2023. Front Neurosci. 2023. PMID: 37732300 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
